Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H22N2O7 |
| Molecular Weight | 414.4086 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC3=CC=CC(O)=C3C(=O)C1=C(O)[C@]4(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]4([H])C2
InChI
InChIKey=XDVCLKFLRAWGIT-ADOAZJKMSA-N
InChI=1S/C21H22N2O7/c1-23(2)15-10-7-9-6-8-4-3-5-11(24)12(8)16(25)13(9)18(27)21(10,30)19(28)14(17(15)26)20(22)29/h3-5,9-10,15,24,26-27,30H,6-7H2,1-2H3,(H2,22,29)/t9-,10-,15-,21-/m0/s1
DescriptionSources: Semi-synthetic antibiotic related to tetracycline. Beereboom et al., J. Am. Chem. Soc. 82, 1003 (1960);
Sources: Semi-synthetic antibiotic related to tetracycline. Beereboom et al., J. Am. Chem. Soc. 82, 1003 (1960);
There is a little information around sancycline. It is known, that it was synthesized by Conover and co-workers in 1962 and it was antibacterial compound. It was proposed that sancycline binds to the 30S of bacterial ribosomal subunit and inhibiting protein translation by blocking entry of aminoacyl-tRNA into the ribosome A site.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1595
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
808-26-4
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | |||
|
54688686
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | |||
|
DTXSID5057836
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL2009312
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | |||
|
3828
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | |||
|
1841
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | |||
|
100000084071
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | |||
|
C98033
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | |||
|
m922
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB10440MIG
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY | |||
|
ODN00F2SJG
Created by
admin on Fri Dec 15 19:01:37 GMT 2023 , Edited by admin on Fri Dec 15 19:01:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
